Pathogenesis of alcoholic liver disease

Hepatology Research - Tập 47 Số 1 - Trang 70-79 - 2017
Kazushi Sugimoto1, Yoshiyuki Takei1
1Department of Gastroenterology and Hepatology, Mie University School of Medicine, Tsu, Mie, Japan

Tóm tắt

Alcoholic liver disease (ALD) has become one of the most critical health problems in many countries, including Japan. Liver injury in ALD ranges from steatosis and steatohepatitis to fibrosis, cirrhosis, and hepatocellular carcinoma. Many factors are thought to contribute to the development and progression of ALD, particularly insulin resistance, generation of reactive oxygen species during alcohol metabolism, adipokines from visceral adipose tissue, and endotoxin derived from the gut. Although the pathogenesis of ALD has been widely investigated, the precise mechanisms are yet to be elucidated and many questions remain. This article reviews the possible mechanisms for the development of ALD identified to date.

Từ khóa


Tài liệu tham khảo

10.1126/science.182.4113.712

10.1126/science.162.3856.917

10.1111/j.1432-1033.1988.tb14305.x

10.1002/hep.510310219

10.1096/fj.00-0650rev

10.2170/jjphysiol.46.15

10.1152/ajpgi.00521.2005

10.1002/hep.510280521

10.1016/j.freeradbiomed.2007.01.044

Koop DR, 1982, Purification and characterization of a unique isozyme of cytochrome P‐450 from liver microsomes of ethanol‐treated rabbits, J Biol Chem, 257, 8472, 10.1016/S0021-9258(18)34356-4

10.1016/0006-2952(89)90338-9

10.1002/hep.510230121

10.1016/S0891-5849(01)00743-2

10.1016/j.freeradbiomed.2010.07.026

10.1097/01.ALC.0000089958.65095.84

10.1111/j.1530-0277.2001.tb02273.x

10.1016/S0300-483X(00)00231-6

10.1111/j.1440-1746.2007.05290.x

10.1111/j.1530-0277.2002.tb02698.x

10.1111/j.1530-0277.2006.00002.x

10.1042/bj1340507

10.1002/hep.1840090223

10.1002/hep.1840160425

10.1172/JCI116334

10.1002/hep.25497

10.1038/nm0204-126

10.1006/bbrc.1999.0255

10.1073/pnas.2333912100

10.1002/hep.20821

10.1210/er.2005-0005

10.1172/JCI200317797

10.1152/ajpendo.00387.2006

10.1002/hep.22074

10.1152/ajpgi.90358.2008

10.1016/j.jhep.2010.12.034

10.1155/2013/148526

10.1210/en.2005-0898

10.1016/S0140-6736(96)03173-X

10.1096/fj.04-2846fje

10.1053/jhep.2002.33684

10.1053/gast.2002.32995

10.1016/j.cmet.2012.05.012

10.1093/jnci/djg090

10.1111/acer.12558

10.2337/diabetes.54.10.2939

10.1074/jbc.273.9.5053

10.1111/j.1530-0277.1992.tb00656.x

10.1002/hep.1840220441

10.1053/gast.2002.34161

10.1002/hep.510260621

10.1111/j.1530-0277.1990.tb00482.x

10.1055/s-2007-1007110

10.1016/j.cell.2009.12.052

10.1074/jbc.M301977200

10.1677/JOE-06-0047

Hill DB, 1992, Increased plasma interleukin‐6 concentrations in alcoholic hepatitis, J Lab Clin Med, 119, 547

10.1126/science.274.5291.1379

Gao B, 2005, Cytokines, STATs and liver disease, Cell Mol Immunol, 2, 92

El‐Assal O, 2004, IL‐6‐deficient mice are susceptible to ethanol‐induced hepatic steatosis: IL‐6 protects against ethanol‐induced oxidative stress and mitochondrial permeability transition in the liver, Cell Mol Immunol, 1, 205

10.1002/hep.27036

Bigatello LM, 1987, Endotoxemia, encephalopathy, and mortality in cirrhotic patients, Am J Gastroenterol, 82, 11

Nanji AA, 1993, Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2, Am J Pathol, 142, 367

10.1111/j.1530-0277.2000.tb00012.x

10.1016/S1521-6918(03)00034-9

10.1152/ajpgi.00006.2004

10.1152/ajpgi.2001.280.6.G1280

10.3892/mmr.2014.2126

10.1042/BJ20060665

10.3109/07853899609033120

10.1371/journal.pone.0053028

10.1186/s12866-014-0240-4

Bode C, 1993, Breath hydrogen excretion in patients with alcoholic liver disease – evidence of small intestinal bacterial overgrowth, Z Gastroenterol, 31, 3

10.1159/000201507

10.1007/s10620-013-2960-y

Bhonchal S, 2007, Modification of small bowel microflora in chronic alcoholics with alcoholic liver disease, Trop Gastroenterol, 28, 64

10.1002/hep.24423

10.1152/ajpgi.00380.2011

10.1172/JCI23621

10.1093/oxfordjournals.aje.a115703

Jequier E, 1999, Alcohol Intake and body weight: a paradox, Am J Clin Nutr, 69, 173, 10.1093/ajcn/69.2.173

10.1016/0140-6736(92)91277-F

10.1161/01.CIR.100.10.1050

10.1046/j.1365-2362.2000.00624.x

10.1056/NEJMoa022095

10.2337/diacare.28.3.719

10.1038/ijo.2008.266

10.1016/j.atherosclerosis.2008.10.036

10.1016/S0168-8278(00)80065-3

10.1053/jhep.2002.31782

10.1111/j.1440-1746.2008.05339.x

10.1016/j.jhep.2009.01.021

10.1111/j.1530-0277.1991.tb00606.x

Patel BC, 1991, Impairment of hepatic insulin receptors during chronic ethanol administration, Am J Physiol, 261, G199

10.1093/alcalc/ags106

10.1074/jbc.M410310200

10.1016/S0006-291X(03)00407-8

10.1152/ajpgi.2000.279.1.G178

10.3389/fgene.2012.00054

10.1111/adb.12037

10.3748/wjg.15.1219

You M, 2015, Sirtuin 1 signaling and alcoholic fatty liver disease, Hepatobiliary Surg Nutr, 4, 88

10.1016/S0016-5085(98)70599-2

10.1002/hep.24001